Table 2.
Prevalence of HEV antibodies among blood donors**.
Continent | Country | Author, Year of Publication | Sample size(N) | IgM reactive(n) | Prevalence (%) | IgG reactive(n) | Prevalence (%) | Screening kit used for HEV IgM antibody | Screening Kit used for HEV IgG antibody | Ref. |
---|---|---|---|---|---|---|---|---|---|---|
Africa | Burkina Faso | Traore et al., 2016 | 1497 | 13 | 1.9 | 584 | 39 | Wantai | DiaPro | [38] |
Asia | China | Ren et al., 2014 | 10741 | 109 | 1.02 | 2945 | 27.4 | Wantai | Wantai | [39] |
Nepal | Shrestha et al., 2016 | 1845 | 55 | 2.98 | 773 | 41.89 | Wantai | Wantai | [40] | |
Qatar | Nasrallah et al., 2017 | 5854 | 34 | 0.58 | 1198 | 20.5 | Wantai | Wantai | [41] | |
China | Wang et al., 2017 | 9069 | 131 | 1.44 | 2682 | 29.5 | Wantai | Wantai | [42] | |
China | Wen et al., 2018 | 5345 | 38 | 0.71 | 1227 | 22.96 | Wantai | Wantai | [43] | |
India | Tripathy et al., 2019 | 2447 | 5 | 0.2 | 433 | 17.7 | Inhouse Prep | Inhouse Prep | [44] | |
China | Cheng X et al., 2019 | 4044 | 43 | 1.1 | 799 | 19.8 | Wantai | Wantai | [45] | |
China (H.K) | Tsoi et al., 2020 | 2000 | 16 | 0.08 | 315 | 15.8 | Wantai | Wantai | [46] | |
Saudi Arabia | Alhatlani et al., 2021 | 1078 | - | - | 61 | 5.7 | - | Fortress Diagnostics, Antrim, UK | [47] | |
China | P. Fu et al., 2021 | 1864 | 21 | 1.13 | 249 | 13.36 | Inhouse Prep | Inhouse Prep | [48] | |
Europe | Scotland (UK) | Cleland et al., 2013 | 1559 | 0 | 0 | 73 | 4.7 | Wantai | Wantai | [49] |
Netherland | Slot et al., 2013 | 1401 | 49 | 3.5 | - | - | Wantai | - | [50] | |
5239 | - | - | 1401 | 26.7 | - | Wantai | ||||
Germany | Juhl D et al., 2014 | 1019 | - | - | 69 | 6.8 | - | recomline | [51] | |
Spain | Sauleda et al., 2015 | 1082 | - | - | 216 116 |
19.96 10.72 |
- | Wantai &, recomline | [52] | |
Austria | Fischer et al., 2015 | 1203 | - | 163 | 13.55 | - | Wantai | [53] | ||
Ireland | O’Riordan et al., 2016 | 1076 | - | - | 57 | 5.3 | - | Wantai | [54] | |
Scotland (UK) | Thom et al., 2018 | 1714 | - | - | 104 | 6.1 | - | Wantai | [55] | |
Netherland | Mooij et al., 2018 | 2100 | - | 648 | 31 | - | Wantai | [56] | ||
Poland | Grabarczyk et al., 2018 | 3079 | 39 | 1.27 | 1340 | 43.52 | Wantai | Wantai | [57] | |
Italy | Spada et al., 2018 | 10011 | 46 | 0.4 | 869 | 8.7 | Wantai | Wantai | [58] | |
Switzerland | Niederhauser et al., 2018 | 3609 | - | - | 737 | 20.4 | - | Wantai | [59] | |
Croatia | Miletic et al., 2019 | 1036 | 46 | 4.44 | 209 | 20.17 | DiaPro and recomline | DiaPro and recomline | [60] | |
Italy | Spada et al., 2022 | 1816 | 33 | 1.8 | - | - | Wantai | - | [61] | |
7172 | - | - | 597 | 8.3 | - | Wantai | ||||
North America | United States of America | Xu et al., 2013 | 1939 | 8 | 0.4 | 364 | 18.8 | Wantai | Wantai | [62] |
United States of America | Stramer et al., 2016 | 4499 | 26 | 0.58 | 329 | 7.3 | MP Diagnostic | MP Diagnostic | [63] | |
United States of America | Zafrullah et al., 2018 | 5040 | 146 | 2.9 | 569 | 11.29 | DSI | DSI | [64] | |
5040 | 93 | 1.85 | 537 | 10.65 | MP Diagnostic | MP Diagnostic | ||||
5040 | 34 | 0.67 | 619 | 12.28 | Wantai | Wantai | ||||
Oceania | New Zealand | Hewitt J et al., 2018 | 1013 | - | - | 98 | 9.7 | - | Wantai and MP Diagnostics | [65] |
** The table was prepared inclusively for articles published before 2010 and sample size less than 1000 numbers in order to limit number of reference allotted for the publication, Inhouse prep; Inhouse preparation, DSI; Diagnostic System Incorporated (DSI S.r.l., Milan, Italy), H.K; Hong Kong.